Emergent BioSolutions (EBS) announced that its Board of Directors has authorized the repurchase of up to $50 million of the company’s common ...

Discover the best strategy games with no main story. These games focus on mechanics and replayability - without the need for a narrative.

Nic Reuben is secretly several Skaven in a trenchcoat that have somehow developed a predilection for weird fiction, onion ...

GAITHERSBURG, Md., March 31, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that its Board of Directors has authorized the repurchase of up to $50 million of the ...

Emergent BioSolutions faces declining revenues, increasing competition, and limited growth potential, leading to a sell rating due to poor risk-reward profile. NARCAN, their main revenue generator ...

Keymed Biosciences Inc. (HKEX: 02162) ('Keymed' or the 'Company') today announced that the prestigious medical journal Nature Medicine has published the results from the Phase III trial of its ...

Emergent BioSolutions has faced significant challenges, with its stock price falling sharply since my previous article in July 2024. The company's updated mission focuses on combating health ...